Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Plasmanate Market Value Growth And Long-Term Outlook
The historical growth can be explained by the increased prevalence of surgical procedures demanding volume replacement, the emergence of plasma fractionation technologies, an uptick in trauma and burn treatment incidents, the implementation of albumin-based therapies, and the expansion of critical care units within hospitals.
Growth anticipated during the forecast period stems from factors such as an increasing demand for safer products derived from plasma, augmented investments in the infrastructure for plasma collection, an expansion in emergency and trauma care services, a heightened focus on therapeutics based on proteins, and advancements in plasma processing technologies. Simultaneously, significant trends expected over this period involve an increased utilization of plasma protein volume expanders, a rising need for therapeutics sourced from blood, a growing emphasis on plasma products that are both safe and pasteurized, an expansion of their applications in critical care, and an enhanced focus on ensuring the traceability of the supply chain.
Get A Free Sample Report With In-Depth Market Insights:
Plasmanate Market Growth Factors Behind Sustained Expansion
The increasing occurrence of trauma cases is anticipated to drive the expansion of the plasmanate market. Trauma situations involve severe physical or psychological injuries stemming from external forces or distressing events, necessitating immediate medical attention, surgery, rehabilitation, and psychological support for recovery. The rise in these cases is attributed to higher accident rates, increased urbanization leading to greater exposure to hazardous circumstances, and shifts in lifestyle choices, such as amplified risk-taking behavior and substance abuse. Patients suffering from trauma can experience hypovolemic shock due to significant blood loss, where plasma transfusion becomes essential for restoring circulating blood volume and maintaining blood pressure. For instance, in 2025, the Wisconsin Department of Health Services (DHS), a U.S.-based state government health agency, reported that Wisconsin trauma cases escalated by approximately 5.6% from 2023 to 2024. Therefore, the growing incidence of trauma cases is a primary factor fueling the plasmanate market’s growth.
Plasmanate Market Segment Trends And Revenue Contributors
The plasmanate market covered in this report is segmented –
1) By Formulation: Liquid Formulations, Lyophilized Formulations
2) By Clinical Indication: Hypovolemia, Burns, Shock, Hypoproteinemia, Surgical Procedures
3) By Distribution Channel: Online Pharmacies, Wholesale Distributors
4) By End User: Hospitals, Clinical Research Laboratories
Plasmanate Market Competitive Landscape: Which Companies Lead The Industry?
Major companies operating in the plasmanate market are Grifols Therapeutics LLC
View The Full Plasmanate Market Report:
Plasmanate Market Geographic Analysis: Where Is Demand Accelerating Fastest?
North America was the largest region in the plasmanate market in 2025. The regions covered in the plasmanate market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
